Edmund Dunn Monte Rosa Therapeutics, Inc. (GLUE) insider trading activity
Edmund Dunn is Principal Accounting Officer of Monte Rosa Therapeutics, Inc.. Currently has a direct ownership of 13,944 shares of GLUE, which is worth approximately $116,571. The most recent transaction as insider was on Jul 05, 2024, when has been sold 1,610 shares (Common Stock) at a price of $3.83 per share, resulting in proceeds of $6,166. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
13.9K
0%
3M change
n/a
12M change
Total Value Held
$116,571
ED
Edmund Dunn
Principal Accounting Officer
Boston, MA